Latest Insider Transactions at Johnson & Johnson (JNJ)
This section provides a real-time view of insider transactions for Johnson & Johnson (JNJ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of JOHNSON & JOHNSON to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of JOHNSON & JOHNSON's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 30
2020
|
Michael E Sneed EVP, Global Corp Aff & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
58,128
+35.09%
|
$3,603,936
$62.62 P/Share
|
|
Dec 13
2019
|
Hubert Joly Director |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$705,000
$141.28 P/Share
|
|
Dec 12
2019
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
SELL
Open market or private sale
|
Direct |
2,017
-3.9%
|
$284,397
$141.07 P/Share
|
|
Dec 12
2019
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,017
+3.75%
|
$125,054
$62.62 P/Share
|
|
Sep 11
2019
|
William D Perez Director |
SELL
Bona fide gift
|
Direct |
2,692
-14.77%
|
-
|
|
Jun 11
2019
|
Marillyn A Hewson Director |
BUY
Open market or private purchase
|
Direct |
3,000
+50.0%
|
$417,000
$139.68 P/Share
|
|
May 07
2019
|
Michael H Ullmann Exec VP, General Counsel |
SELL
Bona fide gift
|
Direct |
353
-0.27%
|
-
|
|
Feb 28
2019
|
Michael H Ullmann Exec VP, General Counsel |
SELL
Bona fide gift
|
Direct |
736
-0.55%
|
-
|
|
Feb 11
2019
|
Joaquin Duato CEO and Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
11,435
-9.07%
|
$1,497,985
$131.94 P/Share
|
|
Feb 11
2019
|
Joaquin Duato CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
3,710
+2.86%
|
-
|
|
Feb 11
2019
|
Joaquin Duato CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
22,624
+15.6%
|
-
|
|
Feb 11
2019
|
Alex Gorsky Director |
SELL
Payment of exercise price or tax liability
|
Direct |
37,374
-8.76%
|
$4,895,994
$131.94 P/Share
|
|
Feb 11
2019
|
Alex Gorsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,127
+2.76%
|
-
|
|
Feb 11
2019
|
Alex Gorsky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
73,947
+15.13%
|
-
|
|
Feb 11
2019
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
SELL
Payment of exercise price or tax liability
|
Direct |
3,578
-15.53%
|
$468,718
$131.94 P/Share
|
|
Feb 11
2019
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
BUY
Grant, award, or other acquisition
|
Direct |
1,237
+5.09%
|
-
|
|
Feb 11
2019
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
BUY
Exercise of conversion of derivative security
|
Direct |
7,541
+25.69%
|
-
|
|
Feb 11
2019
|
Jorge S. Mesquita Exec VP, WW Chair, Consumer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,577
-29.74%
|
$1,516,587
$131.94 P/Share
|
|
Feb 11
2019
|
Jorge S. Mesquita Exec VP, WW Chair, Consumer |
BUY
Grant, award, or other acquisition
|
Direct |
2,783
+6.67%
|
-
|
|
Feb 11
2019
|
Jorge S. Mesquita Exec VP, WW Chair, Consumer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,968
+31.95%
|
-
|
|
Feb 11
2019
|
Michael E Sneed EVP, Global Corp Aff & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,497
-6.61%
|
$458,107
$131.94 P/Share
|
|
Feb 11
2019
|
Michael E Sneed EVP, Global Corp Aff & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
1,193
+2.21%
|
-
|
|
Feb 11
2019
|
Michael E Sneed EVP, Global Corp Aff & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,275
+12.34%
|
-
|
|
Feb 11
2019
|
Paulus Stoffels Vice Chair, Exec Committee |
SELL
Payment of exercise price or tax liability
|
Direct |
15,884
-6.42%
|
$2,080,804
$131.94 P/Share
|
|
Feb 11
2019
|
Paulus Stoffels Vice Chair, Exec Committee |
BUY
Grant, award, or other acquisition
|
Direct |
5,154
+2.04%
|
-
|
|
Feb 11
2019
|
Paulus Stoffels Vice Chair, Exec Committee |
BUY
Exercise of conversion of derivative security
|
Direct |
31,428
+11.48%
|
-
|
|
Feb 11
2019
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
SELL
Payment of exercise price or tax liability
|
Direct |
6,236
-7.8%
|
$816,916
$131.94 P/Share
|
|
Feb 11
2019
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
BUY
Grant, award, or other acquisition
|
Direct |
1,599
+1.96%
|
-
|
|
Feb 11
2019
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
BUY
Exercise of conversion of derivative security
|
Direct |
9,748
+11.06%
|
-
|
|
Feb 11
2019
|
Michael H Ullmann Exec VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
8,151
-5.76%
|
$1,067,781
$131.94 P/Share
|
|
Feb 11
2019
|
Michael H Ullmann Exec VP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,177
+1.51%
|
-
|
|
Feb 11
2019
|
Michael H Ullmann Exec VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
13,273
+8.69%
|
-
|
|
Feb 11
2019
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,047
-8.87%
|
$530,157
$131.94 P/Share
|
|
Feb 11
2019
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,102
+2.36%
|
-
|
|
Feb 11
2019
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,722
+13.11%
|
-
|
|
Feb 11
2019
|
Peter Fasolo Exec VP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,687
-8.01%
|
$1,006,997
$131.94 P/Share
|
|
Feb 11
2019
|
Peter Fasolo Exec VP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,068
+2.11%
|
-
|
|
Feb 11
2019
|
Peter Fasolo Exec VP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,609
+11.83%
|
-
|
|
Feb 11
2019
|
Joseph J Wolk Exec VP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
961
-6.46%
|
$125,891
$131.94 P/Share
|
|
Feb 11
2019
|
Joseph J Wolk Exec VP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
476
+3.1%
|
-
|
|
Feb 11
2019
|
Joseph J Wolk Exec VP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,903
+16.77%
|
-
|
|
Feb 11
2019
|
Ronald A Kapusta Controller, CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
940
-5.03%
|
$123,140
$131.94 P/Share
|
|
Feb 11
2019
|
Ronald A Kapusta Controller, CAO |
BUY
Grant, award, or other acquisition
|
Direct |
466
+2.43%
|
-
|
|
Feb 11
2019
|
Ronald A Kapusta Controller, CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,839
+13.47%
|
-
|
|
Feb 08
2019
|
Joaquin Duato CEO and Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
2,798
-2.73%
|
$369,336
$132.0 P/Share
|
|
Feb 08
2019
|
Joaquin Duato CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
9,049
+8.1%
|
-
|
|
Feb 08
2019
|
Alex Gorsky Director |
SELL
Payment of exercise price or tax liability
|
Direct |
11,708
-3.32%
|
$1,545,456
$132.0 P/Share
|
|
Feb 08
2019
|
Alex Gorsky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,579
+7.74%
|
-
|
|
Feb 08
2019
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
SELL
Payment of exercise price or tax liability
|
Direct |
1,824
-11.33%
|
$240,768
$132.0 P/Share
|
|
Feb 08
2019
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
BUY
Exercise of conversion of derivative security
|
Direct |
6,599
+29.08%
|
-
|